Skip to content

Clinical trials

Observational Aortic Valve Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Aortic Valve Disease Phase: Observational Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20071
20081
20092
20104
20113
20122
20132
20141
20154
20169
20174
20184
20197
20205
202114
20228
20239
20249
20255
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Recruiting21
Unknown status19
Active, not recruiting8
Not yet recruiting6
Terminated4
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices5
Edwards Lifesciences5
Assiut University4
Medical University of Vienna3
Xijing Hospital3
Assistance Publique Hopitaux De Marseille2
Baylor Research Institute2
Catharina Ziekenhuis Eindhoven2
Chinese Academy of Medical Sciences, Fuwai Hospital2
Closed Joint-Stock Company NeoCor2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Aortic Valve Disease104
Aortic Valve Stenosis28
Heart Valve Diseases13
Aortic Valve Insufficiency10
Coronary Artery Disease9
Heart Failure7
Aortic Aneurysm4
Heart Diseases4
Mitral Valve Insufficiency4
Tricuspid Valve Insufficiency4

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.